M. Delaforge

1.7k total citations
55 papers, 1.4k citations indexed

About

M. Delaforge is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, M. Delaforge has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 19 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in M. Delaforge's work include Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (12 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). M. Delaforge is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (12 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). M. Delaforge collaborates with scholars based in France, United Kingdom and Canada. M. Delaforge's co-authors include Daniel Mansuy, Jean‐Luc Boucher, Costas Ioannides, D. V. Parke, J. Custot, Jean‐Pierre Tenu, François André, Jean Luc Boucher, A. Yapo and Michel Lepoivre and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

M. Delaforge

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Delaforge France 20 417 401 375 332 173 55 1.4k
Yoshiji Ohta Japan 27 439 1.1× 739 1.8× 454 1.2× 117 0.4× 193 1.1× 114 2.5k
Isao Ishiguro Japan 23 244 0.6× 679 1.7× 335 0.9× 151 0.5× 73 0.4× 124 1.8k
Peter J. Hanson United Kingdom 23 632 1.5× 624 1.6× 100 0.3× 154 0.5× 73 0.4× 66 1.9k
Thierry Oster France 26 630 1.5× 832 2.1× 111 0.3× 212 0.6× 112 0.6× 55 1.9k
Kouwa Yamashita Japan 28 176 0.4× 856 2.1× 188 0.5× 210 0.6× 237 1.4× 86 2.4k
Soumen K. Manna India 23 142 0.3× 892 2.2× 227 0.6× 330 1.0× 119 0.7× 63 1.9k
Subhash C. Jain India 20 196 0.5× 438 1.1× 675 1.8× 325 1.0× 93 0.5× 62 2.0k
D. Hegner Germany 25 406 1.0× 909 2.3× 170 0.5× 124 0.4× 487 2.8× 80 2.0k
Rita A. Halpin United States 20 161 0.4× 695 1.7× 226 0.6× 141 0.4× 92 0.5× 23 1.4k
Michael Adams Canada 26 198 0.5× 795 2.0× 126 0.3× 141 0.4× 111 0.6× 65 2.0k

Countries citing papers authored by M. Delaforge

Since Specialization
Citations

This map shows the geographic impact of M. Delaforge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Delaforge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Delaforge more than expected).

Fields of papers citing papers by M. Delaforge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Delaforge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Delaforge. The network helps show where M. Delaforge may publish in the future.

Co-authorship network of co-authors of M. Delaforge

This figure shows the co-authorship network connecting the top 25 collaborators of M. Delaforge. A scholar is included among the top collaborators of M. Delaforge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Delaforge. M. Delaforge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoufache, Khaled, Olivier Puel, Nicolas Loiseau, et al.. (2007). Verruculogen associated with Aspergillus fumigatus hyphae and conidia modifies the electrophysiological properties of human nasal epithelial cells. BMC Microbiology. 7(1). 5–5. 60 indexed citations
2.
Aninat, Caroline, François André, & M. Delaforge. (2005). Oxidative metabolism by P450 and function coupling to efflux systems: Modulation of mycotoxin toxicity. Food Additives & Contaminants. 22(4). 361–368. 13 indexed citations
3.
Delaforge, M., Alain Pruvost, Lionel Perrin, & François André. (2004). CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8. Drug Metabolism and Disposition. 33(3). 466–473. 38 indexed citations
4.
Delaforge, M., et al.. (2001). Recognition and oxidative metabolism of cyclodipeptides by hepatic cytochrome P450. Peptides. 22(4). 557–565. 15 indexed citations
5.
Delaforge, M., et al.. (1999). The cyclo‐oxygenase‐dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2‐mediated relaxation. British Journal of Pharmacology. 126(1). 35–44. 5 indexed citations
6.
Boucher, Jean‐Luc, et al.. (1997). Bromocriptine is a strong inhibitor of brain nitric oxide synthase: possible consequences for the origin of its therapeutic effects. FEBS Letters. 406(1-2). 33–36. 11 indexed citations
7.
8.
Delaforge, M., et al.. (1997). Metabolite Involvement in Bromocriptine-Induced Prolactin Inhibition in Rats. Journal of Pharmacology and Experimental Therapeutics. 282(3). 1418–1424. 8 indexed citations
9.
10.
Delaforge, M., et al.. (1995). Particular ability of cytochromes P450 3A to form inhibitory P450-iron-metabolite complexes upon metabolic oxidation of aminodrugs. Biochemical Pharmacology. 49(5). 591–602. 95 indexed citations
11.
Boucher, Jean Luc, J. Custot, M. Delaforge, et al.. (1994). Nω-Hydroxy-L-Arginine, an Intermediate in the L-Arginine to Nitric Oxide Pathway, Is a Strong Inhibitor of Liver and Macrophage Arginase. Biochemical and Biophysical Research Communications. 203(3). 1614–1621. 145 indexed citations
12.
Boucher, Jean‐Luc, et al.. (1992). Formation of nitric oxide by cytochrome P450-catalyzed oxidation of aromatic amidoximes. Biochemical and Biophysical Research Communications. 185(1). 452–458. 48 indexed citations
13.
Boucher, Jean‐Luc, et al.. (1992). Formation of nitrogen oxides and citrulline upon oxidation of Nω-hydroxy-L-arginine by hemeproteins. Biochemical and Biophysical Research Communications. 184(3). 1158–1164. 109 indexed citations
14.
Delaforge, M., et al.. (1992). pH effects on the N-demethylation and formation of the cytochrome P-450 iron II nitrosoalkane complex for erythromycin derivatives. Chemico-Biological Interactions. 85(2-3). 215–227. 19 indexed citations
15.
Boucher, Jean‐Luc, M. Delaforge, & Daniel Mansuy. (1991). Metabolism of lipoxins A4 and B4 and of their all-trans isomers by human leukocytes and rat liver microsomes. Biochemical and Biophysical Research Communications. 177(1). 134–139. 16 indexed citations
16.
17.
Delaforge, M., et al.. (1989). In vitro interaction of rat liver cytochromes P-450 with erythromycin, oleandomycin and erythralosamine derivatives. Biochemical Pharmacology. 38(13). 2061–2068. 21 indexed citations
18.
Servent, Denis, M. Delaforge, Claire Ducrocq, Daniel Mansuy, & M. Lenfant. (1989). Nitric oxide formation during microsomal hepatic denitration of glyceryl trinitrate: Involvement of cytochrome P-450. Biochemical and Biophysical Research Communications. 163(3). 1210–1216. 83 indexed citations
19.
Rouer, Évelyne, M. Delaforge, F. Rocchiccioli, G. Gordon Gibson, & J.P. Leroux. (1985). Spin state studies on cytochrome P-450 in liver microsomes from obese and diabetic animals. Biochemical and Biophysical Research Communications. 126(1). 615–621. 4 indexed citations
20.
Ioannides, Costas, et al.. (1982). Studies on the substrate-binding sites of liver microsomal cytochrome P-448. Biochemical Journal. 207(1). 51–56. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiji Ohta Breakdown of academic impact, for papers by Isao Ishiguro Breakdown of academic impact, for papers by Peter J. Hanson Breakdown of academic impact, for papers by Thierry Oster Breakdown of academic impact, for papers by Kouwa Yamashita Breakdown of academic impact, for papers by Soumen K. Manna Breakdown of academic impact, for papers by Subhash C. Jain Breakdown of academic impact, for papers by D. Hegner Breakdown of academic impact, for papers by Rita A. Halpin Breakdown of academic impact, for papers by Michael Adams
Rankless by CCL
2026